Sinocare Inc
300298
Company Profile
Business description
Sinocare Inc operates in the healthcare industry. It is engaged in the development, manufacturing, and marketing of diagnosis testing products for people with chronic diseases and healthcare professionals. Its product range covers household blood glucose meter, medical blood glucose meter, urinary microalbumin test strip and blood lipid uric acid products. In addition, the company also provides diabetes management information systems.
Contact
No.265 Guyuan Road
Hi-tech Zone
Hunan Province
Changsha410205
CHNT: +86 73189935581
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
4,809
Stocks News & Analysis
stocks
Another incredible quarter from Microsoft
We were wrong when we thought last quarter would be hard to top.
stocks
10 best US dividend aristocrats to buy now—including a surprise outperformer
These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.
stocks
Leading ASX players in this field look materially overvalued
We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,999.00 | 16.40 | -0.18% |
| CAC 40 | 7,783.02 | 78.94 | -1.00% |
| DAX 40 | 24,067.59 | 194.63 | -0.80% |
| Dow JONES (US) | 44,316.91 | 144.37 | -0.32% |
| FTSE 100 | 9,123.12 | 13.82 | -0.15% |
| HKSE | 24,773.33 | 403.60 | -1.60% |
| NASDAQ | 21,240.74 | 111.06 | 0.53% |
| Nikkei 225 | 41,069.82 | 415.12 | 1.02% |
| NZX 50 Index | 12,823.74 | 32.23 | -0.25% |
| S&P 500 | 6,374.71 | 11.81 | 0.19% |
| S&P/ASX 200 | 8,742.80 | 13.60 | -0.16% |
| SSE Composite Index | 3,573.21 | 42.51 | -1.18% |